N syndrome

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Niacin, N-3 Fatty Acids and Insulin Resistance
Status:
Completed
Last Changed:
May 1, 2013
First Changed:
Feb 3, 2006
Disease(s):
Metabolic Syndrome
Intervention(s):
omega-3 acid ethyl estersextended release niacinplaceboomega-3 acid ethyl esterscombined treatment
Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses
Status:
Completed
Last Changed:
Dec 11, 2012
First Changed:
Dec 11, 2012
Disease(s):
Dry Eye Syndrome
Intervention(s):
Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)Physiological saline solution

Connect. Empower. Inspire.